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4Abstract 
 Innate immunity is the first line of defense against invading pathogens. It 
provides immediate protection by initiating both cellular and humoral immune 
reactions in response to a wide range of infections. It is also important to the 
development of long-lasting and pathogen-specific adaptive immunity. Thus, 
studying of the innate immunity, especially the pathogen recognition and 
signaling modulation, is crucial for understanding the intrinsic mechanisms 
underlying the host defense, as well as contributing the development of the fight 
against infectious diseases. 
 Drosophila is an ideal model organism for study of innate immunity. 
Comparing to mammals, Drosophila immunity is relative conserved and less 
redundant. A variety of molecular and genetic tools available add further 
convenience to the research in this system. 
 My work is focused on the signaling modulation by post-translational 
modification after activation. In these studies I demonstrated in the center of Imd 
pathway, the Imd protein undergoes proteolytic cleavage, K63-polyubiquitination, 
phosphorylation, K63-deubiquitination and K48-polyubiquitination/degradation in 
a stimulation-dependent manner. These modifications of Imd play a crucial role in 
regulating signaling in response to infection. The characterization of ubiquitin-
editing event provides a new insight into the molecular mechanisms underlying 
the activation and termination of insect immune signaling pathway. 
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Chapter I:  
Introduction 
11
1.1 Overview 
 Insects and microorganisms have coexisted in this planet for billions of 
years. Therefore, insects have developed a series of mechanisms to protect 
themselves against invading pathogens. For centuries, people are fascinated by 
this elegant system, and numerous researches have been done to explore the 
infection on insects, due to potential benefit on agriculture and public health. 
Since mid 20th century, it has been known that insects are able to mount cellular 
and humoral response to combat infection caused by bacteria, fungi and viruses. 
But the effectors of humoral immune defense remained mysterious until the 
characterization of antimicrobial peptides (AMPs) and their encoding genes 
(Steiner et al., 1981, Hultmark et al., 1983, Kylsten et al., 1990, Samakovlis et al., 
1990, Sun et al., 1991). The discovery of AMPs leads to two major questions in 
the field of insect innate immunity: how are pathogens recognized and how is 
expression of antimicrobial peptides regulated. The genetic and molecular tools 
available in the Drosophila make it an excellent model system for studying insect 
immunity. 
 Comparing to vertebrate, Drosophila provides many advantages as a 
model organism. For starters, its size and life cycle make it easier and cheaper to 
maintain and faster to propagate than most animals. Furthermore, Drosophila 
provides a number of powerful genetic tools. The Drosophila genome has been 
fully sequenced (Adams et al., 2000) and the collections of mutant and 
transgenic lines keep expanding due to application of chemical mutagenesis, 
such as ethyl methanesulfonate (EMS) (Jenkins, 1967), and Transposon-
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mediated mutagenesis (Rubin and Spradling, 1982). In addition, the introduction 
of GAL4/UAS system provides spatio-temporal control of gene expression (Brand 
and Perrimon, 1993), and the regulation by this binary system is further 
strengthened with the combination of RNA interference (RNAi), which expresses 
a hairpin dsRNA construct targeting the gene of interest (Kennerdell and 
Carthew, 2000). Most importantly, many major Drosophila pathways, including 
immunity, are relatively conserved, and unlike mammalian counterpart, 
Drosophila contains a much smaller genome and a system with lower level of 
redundancy, providing a simplified, but reliable model system. 
1.2 Drosophila immune response 
 Throughout the evolution, Drosophila has developed sophisticated 
mechanisms to defend itself against bacteria, fungi, viruses and parasites. 
Lacking a fully evolved adaptive immune system, Drosophila relies on a multi-
layer innate immunity, part of which is shared with higher organisms. It starts with 
epithelia functioning both as physical barrier and local defense against 
pathogens by producing antimicrobial peptides and reactive oxygen species. 
Breaching of these barriers triggers cellular response including phagocytosis, 
encapsulation and melanization, carried out by specialized hemocytes. At last, 
the fat body, a functional equivalent of mammalian liver, initiates humoral 
response by producing immune effectors, such as antimicrobial peptides, through 
two distinct NF-κB signaling pathway: Imd and Toll pathway (Hetru and 
Hoffmann, 2009). 
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Antimicrobial peptides (AMPs) 
A hallmark of research on insect immunity is the characterization of 
antimicrobial peptides (AMPs). The AMPs are produced in the fat body through 
Toll and/or Imd pathway, and the expression of AMPs can be restricted locally 
due to breach of epithelial tissues (Ferrandon et al., 1998, Tzou et al., 2000, Liehl 
et al., 2006), or systemic by secretion into the hemolymph (Ferrandon et al., 
2007). The concentration of AMPs in immune challenged flies can reach 1µM to 
100µM within hours. So far, these small, cationic molecules are classified as 
seven types (Figure 1.1). Diptericin, Drosocin and Attacin are effective against 
Gram-negative bacteria (Wicker et al., 1990, Asling et al., 1995, Charlet et al., 
1996), while Defensin counteract Gram-positive bacteria (Dimarcq et al., 1994). 
Cecropin is potent against both bacteria and fungi (Kylsten et al., 1990, Ekengren 
and Hultmark, 1999), whereas Drosomycin and Metchnikowin are active against 
fungi (Fehlbaum et al., 1994, Levashina et al., 1995). These AMPs are 
membrane active, but their mechanisms are still unclear. 
Recognition of pathogens 
 The selective induction of AMPs towards different types of pathogens 
indicates that Drosophila developed a series of sensing mechanisms to 
differentiate between Gram-negative, Gram-positive bacteria and fungi. The 
recognition of bacteria is achieved through sensing of specific form of 
peptidoglycan (PGN) by Peptidoglycan Recognition Proteins (PGRPs). PGN is 
an essential building block of cell walls of both Gram-negative and Gram-positive 
bacteria. It consists of long glycan chains of alternating N-acetylglucosamine 
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(GlcNAc) and N-acetylmuramic acid (MurNAc) residues that are cross-linked to 
each other by short peptide bridges (Mengin-Lecreulx and Lemaitre, 2005). 
Based on the residue at the third position of the bridge peptide, it can be divided 
into two sub-classes: DAP (meso-diaminopimelic acid)-type PGN that is 
presented on Gram-negative bacteria and certain Gram-positive bacteria, such 
as Bacillus, and Lysine-type PGN that exists on Gram-positive bacteria. In 
addition, TCT is another monomeric form of DAP-type PGN that only contains a 
disaccharide tetra–peptide fragment (Kaneko et al., 2004, Stenbak et al., 2004). 
Drosophila genome encodes 13 PGRP genes and 17 alternative splicing 
forms of receptor proteins. All members of this family contain a PGRP domain 
that is homologous to bacteriophage type–II amidases, enzymes that cleave the 
bond between glycan chain and bridge peptide (Mellroth et al., 2003). Based on 
the existence of the type–II amidases enzymatic activity, PGRPs can be 
classified into two groups: catalytic PGRPs (PGRP–SB1, –SB2, –SC1, –SC2, –
LB) that are involved in degrading PGN and down-regulation of immune 
response, and recognition PGRPs (PGRP–SA, –SD, –LC, –LE, -LF) that function 
as PGN-binding receptors (Bischoff et al., 2004, Mellroth et al., 2003, Zaidman-
Remy et al., 2006), while the function of remaining PGRP-LA and –LD are still 
not clear (Royet and Dziarski, 2007). Based on the size, Drosophila PGRPs can 
also be categorized as short PGRPs (PGRP-S) and long PGRPs (PGRP-L). 
Most short PGRPs contain a signal sequence rather than a transmembrane 
domain, which indicates they are likely to be secreted proteins, whereas most 
long PGRPs are transmembrane receptors with a single-pass transmembrane 
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domain, except intracellular receptors, such as PGRP-LE, which lacks both 
signal peptide and transmembrane domain. 
Catalytic PGRPs play a crucial role in down regulating immune response 
by digestion of PGN. Unlike recognition PGRPs, catalytic PGRPs demonstrated 
zinc-dependent amidase activity that cleaves peptides from glycan chains, 
thereby eliminating PGN to prevent long-term activation of signaling pathway. 
PGRP-LB has been shown to degrade DAP-type PGN, while PGRP-SC is known 
to digest both DAP-type and Lysine-type PGN (Mellroth et al., 2003, Zaidman-
Remy et al., 2006). 
Two members of the recognition PGRPs, membrane receptor PGRP-LC 
and cytosolic receptor PGRP-LE mediate the detection of DAP-type PGN and/or 
TCT, leading to activation of Imd signaling pathway (Takehana et al., 2002, 
Swaminathan et al., 2006, Kaneko et al., 2006), whereas secreted receptors 
PGRP-SA, PGRP-SD, coupled with GNBP1, a Gram-Negative Binding Protein, 
recognize Lysine-type PGN, activating the Toll pathway (Gobert et al., 2003, 
Bischoff et al., 2004, Wang et al., 2006, Wang et al., 2008b). Similar to Gram-
positive bacteria, fungi infection leads to activation of Toll pathway through 
GNBP3, which binds β-(1,3)-glucans, a component of fungal cell wall (Gottar et 
al., 2006). 
Imd pathway 
 Imd pathway (Figure 1.2), initially defined by the identification of mutation 
named immune deficiency (imd) that inhibited the expression of several 
antimicrobial peptides, is activated by DAP-type PGN polymer or monomer  
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(TCT), presented on Gram-negative bacteria and certain Gram-positive bacteria, 
such as Bacillus. Genetic experiments showed that three sets of PGRPs mediate 
PGN dependent Imd signaling. Membrane receptors PGRP-LCx and PGRP-LCa 
are responsible for recognition of TCT (Kaneko et al., 2004, Stenbak et al., 
2004), whereas PGRP-LCx is the sole receptor recognizing polymeric form of 
PGN. In addition, intracellular receptor PGRP-LE is able to interact with both 
polymeric and monomeric form of PGN in the cytosol (Kaneko et al., 2006, Yano 
et al., 2008).  
The PGN binding triggers the dimerization of PGRP-LC and leads to 
activation of downstream protein Imd through the N-terminal cytoplasmic 
domains that is homologous to mammalian RIP Homotypic Interaction Motif 
(RHIM), aka RHIM-like domain. RHIM is required for interaction between TRIF-
RIP1-RIP3 and NF-κB activation in TLR signaling (Meylan et al., 2004). 
However, the RHIM-like domains are critical for Imd signaling but not the 
interaction between PGRP-LC and its immediate downstream factor Imd. 
Instead, they interact with each other via a region that is not required for 
signaling (Kaneko et al., 2006). So far it remains mysterious how the signal is 
transduced through the RHIM-like domains, and there might be additional 
adaptors associated with the receptor-Imd complex through RHIM-like domain. 
Receptor binding and dimerization trigger proteolytic cleavage of Imd by 
FADD and caspase-8 like protein DREDD, exposing an Inhibitor of apoptosis 
(IAP) binding motif, which allows Imd to interact with the Baculovirus IAP Repeat 
(BIR) domain of the ubiquitin E3 ligase Drosophila Inhibitor of apoptosis 2 
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(DIAP2) (Paquette et al., 2010). Imd is a death domain protein similar to 
Receptor Interacting Protein (RIP1) in TNF-R (Tumor Necrosis Factor Receptor) 
pathway. The cleaved Imd is then conjugated with K63-polyubiquitin chains by 
the ubiquitination machinery including E3 ligase Diap2 and three E2 ubiquitin-
conjugating enzymes: Effete (Ubc5 homolog), Bendless (Ubc13 homolog) and 
Uev1a. Similar to mammalian NF-κB signaling, the K63-polyubiqutin chains are 
predicted to function as a scaffold to recruit downstream kinases TGFβ activating 
kinase 1 (TAK1) through the conserved K63-polyubiquitin binding domain of its 
binding partner TAB2. However, the mechanism of kinase activation by K63-
polyubiquitin chains remains unclear. Signaling through TAK1/TAB2 complex 
leads to induction of two downstream branches: JUN N-terminal kinase (JNK) 
pathway and NF-κB/Relish pathway (Silverman et al., 2003). 
 In the JNK pathway branch, activated TAK1 complex phosphorylates the 
Drosophila MKK7/JNKK homolog Hemipterous (Sluss et al., 1996, Holland et al., 
1997, Chen et al., 2002), which in turn phosphorylates Basket (JNK) that 
ultimately leads to the transcriptional activation of Drosophila Activator protein 1 
(AP-1). The JNK branch is not only involved in differentiation and apoptosis 
(Varfolomeev and Ashkenazi, 2004, Dhanasekaran and Reddy, 2008), but also 
suggested to play a role in the up-regulation of stress response and wound repair 
(Boutros et al., 2002, Silverman et al., 2003), yet the precise model remains 
controversial. Interestingly, both side arms of Imd signaling crosstalk with each 
by negative regulation, such as inhibition of JNK pathway by transcriptional target 
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of NF-κB signaling and blocking of NF-κB by AP-1 recruited histone deacetylases 
(Park et al., 2004, Kim et al., 2005). 
 In parallel to JNK pathway, TAK1 also signals to IKK complex and leads to 
activation of NF-κB protein Relish (Vidal et al., 2001, Silverman et al., 2003). The 
IKK complex consists of two subunits: a catalytic kinase subunit encoded by ird5 
(IKKβ) and a regulatory subunit encoded by kenny (IKKγ) (Rutschmann et al., 
2000, Silverman et al., 2000). Similar to mammalian NF-κB precursors p100 and 
p105, Relish is comprised of an N-terminal Rel homology domain (RHD) and an 
inhibitory IκB domain that sequests the protein in the cytoplasm. Upon infection, 
Relish undergoes two distinct but coordinated modification: phosphorylation and 
proteolytic cleavage. Relish is phophorylated by activated IKK complex at Serine 
residues 528 and 529 in the N-terminus, an event that is critical for transcriptional 
modulation of Relish target genes rather than cleavage of Relish itself (Erturk-
Hasdemir et al., 2009). Meanwhile, Relish is also endoproteolytically cleaved by 
a caspase, releasing the N-terminal RHD transcription factor that gets 
translocated into the nucleus to activate target genes. The cleavage event occurs 
after residue D545 found in a typical caspase target motif, 542LQHD545. The 
caspase-8 homolog DREDD is not only associated with Relish (Zhou et al., 
2005), but also necessary and sufficient to drive Relish cleavage (Stoven et al., 
2003, Leulier et al., 2002, Erturk-Hasdemir et al., 2009), suggesting it is a likely 
candidate for such function. In addition, IKK complex is also involved in the 
Relish cleavage non–catalytically (Erturk-Hasdemir et al., 2009). However, the 
mechanism is still unclear. 
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Negative regulation of the Imd pathway 
 Imd pathway is negatively modulated by a series of mechanisms at 
different steps of signaling event (Figure 1.3). As mentioned above, the catalytic 
PGRPs possess type–II amidases enzymatic activity that cleaves the bond 
between glycan chain and bridge peptide. Digestion of PGN by type–II amidases 
significantly reduces its immunostimulatory activity (Werner et al., 2003, Kaneko 
et al., 2004). PGRP-SC and –LB, both of which target DAP-type PGN for 
digestion, are expressed in the gut epithelial and play a crucial role in maintaining 
Drosophila gut homeostasis by preventing potentially pathological consequences 
of excessive and/or prolonged immune activity. Particularly, the Imd pathway in 
the gut is not activated until the PGN–degrading activity of PGRP–LB is 
saturated. Also during larvae stage, RNAi knockdown of PGRP–SC leads to 
increased developmental defects and lethality (Bischoff et al., 2006). Meanwhile, 
PGRP-SC and –LB are transcriptional targets of Imd signaling. Activation of Imd 
pathway leads to expression of catalytic PGRPs that digest the microbial 
stimulus in a negative feedback loop. Moreover, PGRP-LF, one of the recognition 
PGRPs, appears to be another negative regulator of Imd pathway. Depletion of 
PGRP-LF is sufficient to trigger Imd signaling in the absence of infection (Maillet 
et al., 2008), and over-expression of PGRP-LF leads to reduced up-regulation of 
AMPs expression upon infection (Persson et al., 2007). Structure analysis 
showed that instead of binding DAP-type PGN, PGRP-LF competes with PGRP-
LCa to bind to PGRP-LCx, forming bait receptors that prevent signaling in 
response of TCT (Basbous et al., 2011). 
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Downstream of the PGN recognition, multiple cytoplasmic components of 
Imd pathway are negatively regulated in a stimulation-dependent manner. Pirk 
(aka Rudra), appearing to be a transcriptional target of Relish, is believed to 
target PGRP-LC in a negative feedback loop (Lhocine et al., 2008, Kleino et al., 
2008, Aggarwal et al., 2008). SkpA is the homolog of the human Skp1 protein, a 
subunit of SCF–E3 ubiquitin ligase targeting substrates for K48-polyubiquitination 
and proteasomal degradation. Mutations in SkpA, including the other two 
Drosophila SCF component, Slimb and dCullin1, constitutively induce Imd 
signaling, and RNAi targeting skpA or slimb leads to the accumulation of both full 
length and cleaved forms of Relish. Therefore, it was hypothesized that the 
SkpA, Slimb and dCullin regulate the Imd pathway by controlling Relish stability 
(Khush et al., 2002). Defense repressor 1 (Dnr1), a conserved protein with C-
terminal RING finger, has been shown to be able to block signaling by over-
expression and induce Diptericin expression in the absence of infection by RNAi 
(Guntermann et al., 2009). In addition, Caspar, homolog of human Fas 
associated factor 1 (hFAF1), is also a negative regulator if Imd signaling. caspar 
mutant flies show constitutive expression of Diptericin in the absence of infection 
and mutation of caspar protects flies against mildly pathogenic bacteria (Kim et 
al., 2006), instead of hyper-susceptibility caused by hyper-activation of signal 
transduction, like those mutants discussed above. Both of Dnr1 and Caspar are 
suggested to block signaling by disrupting Relish cleavage through degradation 
of DREDD, but this model requires further experiments.  
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 Deubiquitination has been shown to be another crucial negative regulator 
of Imd pathway. Identification of Drosophila Ubiquitin specific protease 36 
(dUSP36) leads to the findings that it prevents signaling by removing the K63-
polyubiquitin chains from Imd, and dUsp36 mutant flies show constitutive 
activation of the Imd pathway and are more sensitive to infection (Thevenon et 
al., 2009). 
 Imd pathway is also negatively modulated at the transcriptional level. As 
mentioned above, two branches of Imd signaling, JNK pathway and NF-κB 
pathway, are mutually inhibited by each other. Transcription factor AP-1 from 
JNK signaling forms ‘repressosome’ with histone deacetylase dHDAC1 and 
Stat92E, another transcription factor activated by JAK/STAT pathway. This 
complex not only competes with Relish for the κB sites in the promoter/enhancer 
regions of Relish–dependent AMP genes, but also promotes hypoacetylation of 
these transcription regulatory regions, leading to inhibition of NF--κB signaling 
(Park et al., 2004, Kim et al., 2005). On the other hand, Relish branch regulates 
JNK signaling by affecting TAK1 stability. Particularly, POSH, an RING domain-
containing E3 ligase, promote K48-polyubiquitination and degradation of TAK1 
through proteasome (Tsuda et al., 2005). 
Toll Pathway 
 The Toll pathway is triggered by Gram-positive bacteria and fungi (Figure 
1.4). Unlike mammalian TLRs and Imd pathway, in which membrane receptors 
directly binds pathogen-derived compound, Toll is activated by cytokine Spätzle 
(SPZ), a disulfide-linked dimeric protein that can be proteolytically cleaved by  
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serine protease. The recognition of pathogens through Toll pathway requires 
Lysine-type PGN sensor PRGP-SA, PGRP-SD and GNBP1, or GNBP3 that 
detects β-(1,3)-glucans derived form fungi. Recognition by these extracellular 
receptors triggers different serine protease cascades and converge upon 
activation of the SPZ processing enzyme (SPE) (Jang et al., 2006), which in turn 
cleaves and activates SPZ. 
 The cleaved SPZ associates with Toll receptor and induce the 
dimerization of ligand/receptor complex (2xSPZ, 2xToll) (Mizuguchi et al., 1998, 
Weber et al., 2003, Weber et al., 2005, Gangloff et al., 2008). In the intracellular 
side, dimerized receptors interact with an adapter protein, dMyd88 (homolog of 
mammalian Myd88), through TIR (Toll/IL-1R) domain on both proteins, while 
dMyd88 interacts with Tube and kinase Pelle (homolog of mammalian IRAK) 
through Death domain found in each protein (Towb et al., 1998, Tauszig-
Delamasure et al., 2002, Sun et al., 2002). The ligand-binding induced 
association of intracellular adapter proteins is similar to the recruitment of 
mammalian IRAK via an adapter complex in Myd88-dependent TLR signaling. 
 Similar to Imd pathway, activation of Toll pathway culminates in the 
nuclear translocation of the NF-κB proteins Dorsal and/or DIF (Dorsal related 
immunity factor). Dorsal was initially identified as a key regulator in dorsal-ventral 
patterning during embryogenesis (Santamaria and Nusslein-Volhard, 1983). DIF 
mediates Toll pathway in both larvae and adults, whereas Dorsal is only required 
for signaling during larva stage. Both DIF and Dorsal are sequestered in the 
cytoplasm by its interaction with the IκB protein Cactus. Signaling from upstream 
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triggers phosphorylation and K48-polyubiquitination of Cactus, leading to its 
degradation through proteasome (Reach et al., 1996, Bergmann et al., 1996, Liu 
et al., 1997, Fernandez et al., 2001). However, the kinase that directly 
phosphorylates Cactus is yet to be identified.  
The degradation of Cactus releases DIF/Dorsal and leads to the their 
nuclear translocation, initiating expression of immune responsive genes (Irving et 
al., 2001, De Gregorio et al., 2002), including AMPs and other less well 
characterized targets, such as regulators of cellular immune response and 
hemocyte proliferation (Qiu et al., 1998, Zettervall et al., 2004). Most notably, 
Cactus is up–regulated via the Toll pathway, a typical negative feedback loop to 
down–modulate the cascade (Nicolas et al., 1998). 
Negative regulation of the Toll pathway 
Besides Cactus-mediated negative feedback, Toll signaling is down 
regulated at different steps of the cascade (Figure 1.4). On the top, PGRP-SC is 
able to digest Lysine-type PGN and prevent constitutive activation by pathogen. 
Downstream of the microbial recognition, PSH, which is one of the serine 
proteases that leads to cleavage of SPZ, is inhibited by serine protease inhibitor 
Necrotic. In the cytosol, wnt inhibitor of Dorsal (WntD), a transcriptional target of 
Toll signaling, is capable of blocking the nuclear translocation of Dorsal. This 
mechanism regulates the Toll pathway in embryonic patterning and possibly also 
in the context of immunity (Ganguly et al., 2005, Gordon et al., 2005, Gordon et 
al., 2008). 
Ubiquitination 
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 Ubiquitination is a reversible, ATP-dependent posttranslational 
modification, and a powerful mechanism that regulates almost every aspect of 
eukaryotic cell physiology. Ubiquitination of substrate protein is achieved through 
an enzymatic cascade requiring three classes of enzymes: E1 ubiquitin activating 
enzyme, E2 ubiquitin conjugating enzyme and E3 ubiquitin ligase (Hershko et al., 
1983) (Figure 1.5). The extensive participation of ubiquitination machinery in 
physiological reaction leads to a huge family of enzymes. For example, the 
human genome encodes at least 38 E2s and more than 1,000 E3s. Initially, the 
ubiquitin is activated in an ATP-dependent manner by E1, and the C-terminal 
glycine of ubiquitin forms a thioester bond with an active cysteine of the E1. 
Activated ubiquitin is then transferred to a cysteine residue of the E2 via a similar 
thioester linkage. In a final step, the E3 brings the substrate to the ubiquitin-
loaded E2 and promotes the transfer of ubiquitin from E2 to substrate via an 
isopeptide bond formed between the C-terminal glycine of the ubiquitin and a 
lysine on the target protein. 
 Active E2s contain a core ubiquitin-conjugating (UBC) domain that shares 
a high degree of sequence homology among different E2s. They adopt similar 
structures with the HPN tripeptide (histidine-proline-asparagine) and a catalytic 
active cysteine generally located at the eighth amino acid on the C-terminal side 
of this signature motif (Cottee et al., 2006). Ubiquitin E2 variant (UEV) proteins 
are classified as another major type of E2s, which possess a UBC domain 
lacking an active cysteine site. Instead of catalyzing transfer of ubiquitin, they 
bind an active E2 and regulate its localization, activity or linkage specificity.  
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Rather than simple ubiquitin carriers, E2s have been proved to determine the 
specificity and length of ubiquitin chains. So far, phylogenetic analysis revealed 
17 families of E2s among 7 species (Michelle et al., 2009). 
 Based on the sequence homology of the E2-binding domains, E3s can be 
grouped into two subfamilies: the ones containing homologous to E6-AP carboxyl 
terminus (HECT) domain (Bernassola et al., 2008), and those containing really 
interesting new gene (RING) finger domain (Petroski and Deshaies, 2005). The 
key signature of HECT domain-containing E3s is their intrinsic catalytic activity. 
After binding to an ubiquitin-loaded E2, these E3s are able to transfer the 
ubiquitin onto themselves through a ubiquitin-thioester intermediate with the 
catalytic active cysteine located at the C terminus of the HECT domain, before 
conjugation of ubiquitin to the substrate. On the contrary, the RING-finger E3s 
promote the direct transfer of ubiquitin from the E2s to target protein. 
 The substrate protein can be conjugated with a single ubiquitin to one 
(monoubiquitination) or multiple (multi-monoubiquitination) sites, a signal for 
protein interactions, localization and/or modulation of protein activities. 
Alternatively, the substrate can be modified with a chain of multiple ubiquitin 
molecules (polyubiquitination) that are linked through one of the seven Lysine 
residues or a head-to-tail fashion, in which the C-terminal glycine of one ubiquitin 
is covalently bound to the N-terminal amino group of the previous ubiquitin 
(Pickart and Eddins, 2004, Tokunaga et al., 2009). The type and linkage of the 
ubiquitin modification determines the fate of the target protein. This specificity is 
achieved through the recognition of conjugated ubiquitin by proteins containing 
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ubiquitin-binding motifs, such as ubiquitin-interacting motif (UIM) and ubiquitin-
binding (UBA) domains (Hurley et al., 2006, Dikic et al., 2009). These proteins 
bind to specific type and linkage of ubiquitin modification, and interact with 
downstream effectors of signaling pathways to couple ubiquitination to the 
desired biological outcome. For examples, Lys48-linked polyubiquitin chains 
direct substrates to degradation through 26S-proteasome (Verma et al., 2004, 
Kim et al., 2004, Richly et al., 2005), while Lys63-linked and linear (head to tail) 
polyubiquitin chains mediate the activation of transcription factor NF-κB protein 
(Chen, 2005, Rahighi et al., 2009, Tokunaga et al., 2009). 
 Ubiquitination is a reversible biological processes, the removal of ubiquitin 
molecules from substrate protein is achieved by deubiquitinating enzymes 
(DUBs) (Amerik and Hochstrasser, 2004). It is evident that deubiquitination plays 
a crucial role in regulating signal transduction, a function determined by the type 
of ubiquitin it digests. For examples, K63-deubiquitination prevents signaling by 
disrupting the interaction between K63 polyubiquitin chains and its binding 
partners. In particular two DUBs, USP36 and Cyld, have been implicated to 
down-regulating innate immune signaling pathway in Drosophila (Glittenberg and 
Ligoxygakis, 2007, Thevenon et al., 2009). 
1.3 Mammalian NF-κB signaling pathway 
 Comparing to insects, mammals developed adaptive immune system, 
another layer of defense strategy that provides high specificity and long-lasting 
protection against pathogens. However, the innate immune system recognizes 
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and responds to microorganisms in a generic way, creating the immediate 
defense against infection. 
 The NF-κB pathway is perhaps the most well defined mammalian innate 
immune signaling pathway. There are five members in the NF-κB transcription 
factor family: RelA (p65), RelB, c-Rel, p50 and p52. The last two are processed 
from the precursor proteins p105 and p100, respectively (Gilmore, 2006). These 
proteins share a Rel homology domain that is responsible for dimerization and 
DNA binding. They are sequestered in the cytoplasm by association with 
inhibitory IκB protein. Once the activated pathway signals through the IκB kinase 
(IKK), a complex consists of two catalytically active kinases, IKKα and IKKβ, and 
a regulatory subunit IKKγ (NEMO) (Mercurio et al., 1997, Zandi et al., 1997, 
Rothwarf et al., 1998), the IκB protein is degraded and thus these transcription 
factors form homodimers or heterodimers and bind DNA at κB sites in promoters 
and/or enhancers region of target genes to modulate expression. 
 Overall, two main NF-κB-activating pathways have been described. The 
canonical pathway relies on IKKβ/NEMO-dependent phosphorylation of IκB, 
leading to nuclear translocation of NF-κB complexes, predominantly the 
RelA/p50 heterodimer, whereas the noncanonical pathway depends on IKKα-
mediated phosphorylation of p100, a protein functioning as both the precursor of 
p52 and a RelB-specific inhibitor. 
To activate an appropriate immune response, the host must be able to 
recognize the presence of pathogens or cytokines. Based on the type of ligands, 
there two major groups of receptors in the NF-κB pathway family: cytokine 
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receptors, such as tumor necrosis factor receptor (TNFR) and interleukin 1 (IL-1) 
receptor (IL-1R), and Pattern recognition receptors (PRRs), such as Toll-like 
receptors (TLRs), which identify pathogen-associated molecular patterns 
(PAMPs).  
TLRs are type I transmembrane proteins with a tripartite structure 
including an N-terminal extracellular domain containing leucine rich repeats 
(LRRs) responsible for ligand recognition, a single transmembrane domain, and 
a C-terminal globular cytoplasmic Toll/IL-1 receptor (TIR) signaling domain 
(O'Neill and Bowie, 2007). The TLRs can be further divided into two categories 
based on their cellular localization. TLR1, 2, 4, 5, 6 and 10 reside on the cell 
membrane and respond to extracellular stimuli, such as derivative of pathogen 
cell walls, while TLR3, 7, 8, 9, 11, 12 and 13 are found in the endolysosome and 
are activated mostly by microbial nucleic acids (De Gregorio et al., 2002). Ligand 
binding to the TLRs recruits cytosolic TIR domain-containing adapters to activate 
canonical NF-κB pathway. Based on the adapters recruited, TLRs signaling can 
be grouped into two subcategories: those that are MyD88 (myeloid differentiation 
primary response gene 88)-dependent and those that are MyD88-independent 
(O'Neill and Bowie, 2007).  
Among all 13 TLRs, TLR4, which contains the most complicated 
downstream branches, is the best characterized one (Figure 1.6). Upon 
activation of TLR4-MD2 complex by LPS, MyD88 is recruited to the receptor 
complex via the bridge of TIR-domain containing adapter protein (TIRAP, also 
known as Mal) through TIR domain between each other (Fitzgerald et al., 2001).  
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The N-terminus of MyD88 contains a death domain (DD) that recruits the DD- 
containing serine/threonine kinase interleukin-1- associated kinase-4 (IRAK-4) 
(Wesche et al., 1997). Three member of the IRAK family, IRAK-1, IRAK-2 and 
IRAK-4 display intrinsic kinase activity, whereas IRAK-M (also known as IRAK-3) 
is kinase inactive and thought to act predominantly as a negative regulator 
(Flannery and Bowie, 2010). The interaction between MyD88 and IRAK4 triggers 
IRAK4 autophosphoylation and subsequent recruitment/phosphorylation of 
IRAK1.  This whole complex, including receptor, adapters and IRAKs, has been 
termed as Myddosomes (Gay et al., 2011). Activation of IRAKs recruits TNFR-
associated factor 6 (TRAF6), an E3 ubiquitin (Ub) ligase that is soon to be K63-
polyubiquitinated by E2 complex Ubc13 and Uev1a (Wooff et al., 2004, Lamothe 
et al., 2007). The ubiquitinated TRAF6 functions as a scaffold, recruiting MAP3 
kinase TAK1 (TGFb-activated kinase-1), via the bridge of TAB2/TAB3, which 
contain two ubiquitin binding motifs, an N-terminal CUE domain and a C-terminal 
nuclear protein localization four zinc finger (NZF) domain (Kanayama et al., 
2004). TAK1 is then autophosphorylated and signals to downstream IKK complex 
consisting of IKKα, IKKβ and NEMO (Hacker and Karin, 2006), leading to 
phosphorylation and degradation of IκB. Finally the NF-κB is released from 
cytoplasm and translocated into nucleus, initiating cytokine gene transcription 
(Napetschnig and Wu, 2013). 
While TLR4 activation initially results in MyD88-dependent signaling from 
the plasma membrane, internalization of TLR4 into endosomal compartments 
leads to the other branch of signaling in a MyD88-independent manner (Kagan et 
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al., 2008). Upon activation, TIR adaper TRIF is recruited to TLR4 via bridging 
adaper TRAM (Yamamoto et al., 2003). Engagement of TRIF by TLR4 allows for 
association of both TRAF6 and TRAF3. Activated TRAF3 signals through IKK 
like proteins TBK1 and leads to activation and nuclear translocation of the 
transcription factors interferon regulatory factor 3 and 7 (IRF3 and IRF7), 
modulating the expression of type I interferons (IFN), whereas TRAF6 recruits 
and promotes receptor interacting protein 1 (RIP1) K63-polyubiquitination, which 
leads to activation of TAK1 complex and the IKK complex mediated canonical 
NF-κB pathway (Sato et al., 2003, Gohda et al., 2004). 
 Mammalian NF-κB signaling is not only triggered by pathogens, but also 
activated by cytokines such as tumor necrosis factor (TNF). The TNF receptor 
(TNF-R) superfamily is highly diversified with more than 20 receptors and nearly 
as many ligands throughout the body. Similar to TLR4 pathway, signaling 
through TNF-R is achieved by recruitment of intracellular adapters in a signal-
dependent manner (Figure 1.7). Taking TNF-R1 as an example, the trimeric 
ligand TNFα initiates trimerization of the receptors, which allows binding of the 
TNF-R-associated death domain protein (TRADD) through death domain on 
each other. TRADD subsequently recruits adapter TRAF2, and RIP1 (Hsu et al., 
1996, Idriss and Naismith, 2000). RIP1 is positioned at the center of cell-fate 
decisions. On one side of the branches, it is believed that RIP1 and TRAF2 are 
both K63-ubiquitinated by Uev1A/Ubc13 E2 complex and E3 ligase cIAP1/cIAP2 
(Inhibitor of apoptosis). Ubiquitination signals through TAK1 and IKK complex,  
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leading to canonical NF-κB activation that modulates expression of anti-apoptotic 
genes. On the other branch, TRADD-TRAF2-RIP1 complex dissociates from the 
receptor, recruiting FADD and caspase-8 to induce apoptosis (Micheau and 
Tschopp, 2003). The deubiquitinating enzyme CYLD has been demonstrated to 
promote apoptosis by enhancing the RIP1-FADD interaction (Hitomi et al., 2008, 
Wang et al., 2008a), which suggests that the ubiquitination status of RIP1 may 
steer its activity in two opposite directions. Recent studies showed that IKK 
activation in TNF signaling is dependent on non-K63 polyubiquitin chains and 
Ubc5, an E2 enzyme that is able to synthesize heterogeneous polyubiquitin 
chains, suggesting that TNFα-induced NF-B signaling may utilize ubiquitin chains 
containing different linkages (Xu et al., 2009). 
 Mammalian and Drosophila NF-κB pathway share certain degree of 
similarity. Taking TNF-R1 and Imd signaling as examples (Figure 1.8), the 
transmembrane receptors recognize cytokines or PAMPs, leading to 
ubiquitination of cytosolic adaptor protein RIP1 or its Drosophila homolog Imd. E3 
IAP proteins and E2 enzymes including Ubc5 and/or Ubc13-Uev1a catalyze the 
conjugation of polyubiquitin chains, which function as scaffold to recruit 
downstream TAK1 kinase complex. Then activated TAK1 phosphorylates IKK 
complex and triggers nuclear translocation of NF-κB proteins, eventually inducing 
the expression of target genes. However, A20 functions as a critical negative 
regulator in the TNF-R1 signaling by promoting RIP1 ubiquitin-editing and 
degradation through proteasome. So far, nothing similar has been identified in 
the Drosophila Imd signaling. 
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1.4 Thesis objective 
 Post-translational modification, especially polyubiquitination and 
phosphorylation, has been proved as a crucial regulator of innate immune 
signaling pathway in mammals. Currently, many homologous proteins have been 
shown to play roles in both mammalian and insect innate immunity. However, the 
detail mechanism and biological significance remain elusive. In the work 
presented here I use Drosophila as a model organism to better understand these 
puzzles. In particular, I want to elucidate the fundamental principle underlying the 
regulation of Imd pathway by post-translational modification. By studying 
Drosophila innate immune signaling I hope my work can contribute to the ever-
growing body of knowledge innate immunity and ultimately the development of 
the fight against infectious diseases. 
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2.1 Abstract 
Following microbial infection, Drosophila rapidly induces a battery of antimicrobial 
peptides (AMPs). The Imd pathway responds to DAP-type peptidoglycan, from 
the cell wall of gram-negative bacteria, and activates the NF-kB precursor Relish, 
which drives robust AMP genes expression. This pathway involves both 
proteolytic cleavage and K63-polyubiquitination of Imd, a receptor-proximal 
adaptor protein with similarities to mammalian RIP1. However the precise events 
and molecular mechanisms regulating Imd post-translational modifications 
remain unclear. Here, we demonstrate that Imd is rapidly K63-polyubiquitinated 
at lysine residues 137 and 153 by the sequential action of two E2 enzymes, Ubc5 
and Ubc13-Uev1a, in conjunction with the E3 ligase Diap2. K63-ubiquitination 
activates the kinase Tak1, which feeds back to phosphorylate Imd and triggers 
the removal of K63-polyubiquitin and addition of K48-chains. This ubiquitin 
editing process leads to degradation of Imd by the proteasome, and provides 
another mechanism by which this critical immune signaling pathway is restrained. 
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2.2 Introduction 
 The Imd pathway is largely responsible for the robust antimicrobial 
peptides (AMPs) induction observed following septic bacterial infection in 
Drosophila and thus is critically important for defense against invading pathogens 
(Ferrandon et al., 2007, Lemaitre and Hoffmann, 2007). This pathway is triggered 
by DAP-type peptidoglycan (PGN) from bacterial cell walls.  Immune responsive 
cells recognize PGN through two peptidoglycan recognition proteins (PGRPs): 
the cell surface receptor PGRP-LC and the cytosolic receptor PGRP-LE (Kaneko 
et al., 2006). PGN-recognition by these receptors leads to the cleavage of Imd, a 
key adaptor protein in this pathway, by the caspase 8-like protease Dredd. Once 
cleaved, Imd associates with the E3 ligase Diap2 and is rapidly ubiquitinated.  
This modification leads to the activation of the Drosophila homologs of the Tak1 
and IKK (Paquette et al., 2010), and ultimately to the activation of the NF-κB 
precursor Relish and induction of AMP genes expression.   
 Ubiquitination is a critical regulator of innate immune signaling, especially 
NF-kB pathways in mammals and insects. The number and topology of ubiquitin 
conjugations determine the fate of substrate proteins. For example, K48-
polyubiquitination targets proteins to proteasome for degradation (Glickman and 
Ciechanover, 2002), while K63-polyubiquitin chains often function as scaffolds in 
signaling pathways, recruiting and activating downstream factors (Kanayama et 
al., 2004, Ea et al., 2006). Ubiquitination requires the sequential action of the 
ubiquitin activating enzyme (E1), ubiquitin conjugating enzymes (E2) and 
ubiquitin ligases (E3).  While E3s are critical for substrate recognition, E2s play 
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central role in deciding chain topology (David et al., 2010, Wickliffe et al., 2011). 
In the Drosophila Imd pathway, K63-polyubiquitination of Imd plays a crucial role 
to relay signals to downstream kinases. In particular, we previously have 
demonstrated that Imd polyubiquitination requires the E3 ligase Diap2 as well as 
the E2 ubiquitin conjugating enzymes Ubc5 (Effete) and the Ubc13 (Bendless)-
Uev1a complex (Paquette et al., 2010). Effete, also known as UbcD1, is a 
Drosophila member of the yeast Ubc4/5 family along with the human E2s in the 
Ube2D (UbcH5) group (Treier et al., 1992, Jones et al., 2002, Michelle et al., 
2009). Bendless (UbcD3), is the Drosophila homolog of mammalian 
Ubc13/Ube2N, which dimerizes with ubiquitin enzyme variants (Uevs) to 
generate K63-chains (Jones et al., 2002, Eddins et al., 2006, Michelle et al., 
2009). However, the molecular mechanisms by which these E2s function 
together in Imd polyubiquitination remain unclear. 
 The MAP3 kinase Tak1, complexed with the Drosophila Tab2 homolog 
(Zhuang et al., 2006), is known to function downstream of ubiquitinated Imd 
(Paquette et al., 2010).  Tab2 contains a conserved K63-polyubiquitin binding 
domain (Wang et al., 2001, Zhou et al., 2005), suggesting activation of 
Tak1/Tab2 complex by association with K63-polyubiquitinated Imd. Tak1 is 
required for activation of Drosophila IKK complex, which is essential for activation 
of NF-κB precursor Relish (Vidal et al., 2001, Silverman et al., 2003), the key 
transcription factor leading to induction of AMP genes. 
 In addition to ubiquitination, phosphorylation is another common type of 
post-translational modifications in immune signaling pathway. Signal transduction 
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often relies on cascades of kinase activation and phosphorylation. Previous 
research suggests that Imd is also phosphorylated upon immune stimulation 
(Paquette et al., 2010). However, it is still unknown what kinases are responsible 
for Imd phosphorylation or what functional relevance this modification may have 
for immune signaling and defense.  
Prior to this work, it was demonstrated that Imd is polyubiquitinated and 
phosphorylated, yet no connection has been made between these types of post-
translational modifications. Here we confirm that Imd is rapidly cleaved and K63-
polyubiquitinated upon immune stimulation and further demonstrate that this is 
followed by removal, or deubiquitination, of the K63-chains and addition of K48-
chains.  This ubiquitin editing strongly correlates with Imd phosphorylation and 
requires the K63-activated MAP3K Tak1, creating a feedback loop that 
culminates in the proteosomal destruction of Imd. 
2.3 Results 
Imd is K63- and K48-polyubiquitinated as well as phosphorylated upon 
immune stimulation  
Previously, we have shown that PGN stimulation leads to the caspase-
dependent cleavage and K63-polyubiquitnation of the adaptor protein Imd 
(Paquette et al., 2010).  This earlier work suggested Imd was K63-
polyubiquitinated but not K48-conjugated.  On the other hand, another report 
suggested that Imd was modified by both types of polyubiquitin chains 
(Thevenon et al., 2009).  In order to examine the post-translational modifications 
of Imd more closely, a new assay was developed whereby as single Imd  
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these ubiquitination/degradation events. On the other hand, blocking of 
autophagy by Atg1 RNAi didn’t cause any Imd accumulation (Figure 2.2B), 
suggesting that autophagy is not part of the degradation machinery for Imd. 
To further analyze these modification patterns in vivo, w1118 (Control) flies 
were infected with E.coli and whole animal lysates were assayed by Imd 
immunoprecipitation and immublotting for total ubiquitin or Imd. Diap2 deficient 
(Diap27c) and Imd null (imd10191) flies were included for comparison (Figure 2.3). 
Similar to S2* cells, in vivo Imd exhibited robust but transient infection-induced 
cleavage, ubiquitination, and phosphorylation, while Diap2 null showed increased 
accumulation of cleaved Imd with a complete absence of ubiquitination or 
phosphorylation. Unfortunately, the K48- and K63-specific antibodies did not 
have the sensitivity required for use in these whole animal assays (data not 
shown). Together, these cell-based and whole animal data show that Imd is 
multiply modified following immune activation with cleavage, two types of 
ubiquitination, phosphorylation, and ultimately proteasome-mediated 
degradation. 
K137 and K153 are the sites for Imd ubiquitin conjugation 
 Next, we sought to identify the ubiquitin conjugation sites by mass-
spectrometry of endogenous Imd immuno-purified from S2* cells. Two rounds of 
similar assays demonstrated that lysine residues 137 and 153 were conjugated 
with ubiquitin, as indicated by di-glycine tags (K+114 in the spectrum) following 
trypsin digestion (Figure 2.4A and B). Further quantification analysis showed the  
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relative abundance of polyubiquitin chains with four different linkages (Figure 
2.4C). 
In order to verify the result from mass spectrometry analysis, stable cell 
lines expressing Imd WT, K137R, K153R or K137/153R were generated and 
then transfected with dsRNA targeting the 3’UTR of Imd to knockdown the 
endogenous protein. PGN-stimulated Imd K63- and K48-polyubiquitination were 
completely absent when both lysine residues were mutated to arginine, whereas 
only K63-polyubiquitination showed considerable decrease when either K137 or 
K153 were singly mutated to arginine (Figure 2.5A). Moreover, the signaling 
pathway activity, as measured by induction of the antimicrobial peptide gene 
Diptericin, showed roughly 40% to 50% reduction caused by either lysine 
mutation, and 70% reduction by double lysine mutation (Figure 2.5B). By 
comparison, the control parental cell line showed 10% residual Diptericin  
induction, indicative of the small amounts of imd transcripts that remain after 
RNAi treatment (Figure 2.5C).  These results demonstrate that ubiquitination at 
K137 and K153 is critical for Imd ubiquitination and signaling in S2* cells.   
Imd ubiquitination requires Diap2 and multiple E2s 
 Our previously published work suggested that Diap2 is the E3 ligase for 
Imd K63-polyubiquitination (Paquette et al., 2010). Now, using antibodies specific 
to K63 and K48 ubiquitin, we demonstrate that Imd K63-polyubiquitination is 
prevented by knocking down Diap2, which leads to accumulation of cleaved Imd 
and a failure to generate K48-conjugated Imd (Figure 2.6A).  Coincident with this  
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lack of ubiquitination, Diptericin induction is also blocked with Diap2 knockdown 
(Figure 2.6B, and 2.6C for RNAi efficiency). The accumulation of cleaved Imd in  
this assay, as well as in adult Diap2 mutant animals (Figure 2.3), strongly argues 
that Imd cleavage occurs prior to K63-polyubiquitination. 
In order to examine the detailed mechanism of Imd ubiquitination, we 
sought to more thoroughly characterize the role of three different E2 enzymes 
previously implicated: Ubc5, Ubc13 and Uev1a. RNAi targeting each of these 
E2s was first optimized such that knockdown was at least 90% efficient, as 
measured by qRT-PCR (Figure 2.7). Each E2 was knocked-down individually or 
in all possible combinations. Strikingly, total and K63-polyubiquitination was 
completely abolished by Ubc5 depletion, while a low level (20%-50%) of 
ubiquitination signal (both total and K63) remained after knockdown of Ubc13 
and/or Uev1a (Figure 2.8A). The induction of Diptericin showed a similar pattern 
(Figure 2.8A, bottom panel). Knockdown of Ubc5 prevented Diptericin induction, 
while cells depleted of Ubc13 and/or Uev1a still induced a low level (5%-15%). 
Similarly, K48-polyubiquitination was also blocked in absence of Ubc5 (Figure 
2.8B). On the other hand, the level of K48-polyubiquitination observed with 
Ubc13 and/or Uev1a RNAi was mostly unchanged, suggesting that neither of 
these two E2s are involved in Imd K48-polyubiquitination. Together, these data 
indicate that Imd K63-polyubiquitination requires three E2 factors, which play 
distinct roles in the process, as discussed in more detail below. 
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Tak1 is required for Imd phosphorylation and ubiquitin editing  
 In addition to ubiquitination, Imd is also phosphorylated upon immune 
stimulation and the timing of this modification closely track with K48-
ubiquitination (Figure 2.1A). Tak1, a K63-polyubiquitin activated MAP3K that  
functions downstream of Imd K63-polyubiquitination, is implicated in Imd 
phosphorylation (Paquette et al., 2012). In order to determine if Tak1 is required 
for Imd phosphorylation, S2* cells were treated with dsRNA targeting GFP or 
Tak1, followed by PGN stimulation (Figure 2.9A, RNAi efficiency shown in Figure 
2.9B). Imd phosphorylation and K48-polyubiquitination were lacking in the Tak1 
knockdown cells, while the Imd K63-polyubiquitination persisted at later time 
points. Similarly, inhibition of Tak1 by 5Z-7-Oxozeaenol showed significant 
accumulation of Imd K63-polyubiquitination, reduced Imd phosphorylation, loss of 
K48-polyubiquitination and accumulation of cleaved unphosphorylated Imd 
(Figure 2.9C). These results demonstrate that Tak1 is required for Imd 
phosphorylation, K63-deubiquitination and the addition of K48-polyubiquitination. 
To further confirm the functional relevance of Tak1 in Imd modification in 
vivo, wild type or Tak1 deficient flies (Tak12) were challenged with E.coli and 
analyzed for Imd phosphorylation (Figure 2.10).  The Tak12 strain showed a lack 
of Imd phosphorylation indicating that Tak1 is required for Imd phosphorylation in 
vivo. 
 To determine if ectopic expression of Tak1 is sufficient to drive Imd 
phosphorylation, a stable cell line expressing FLAG-Tak1 from the Cu2+ inducible  
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metallothionein promoter was treated with CuSO4 for 6 hours followed by PGN 
stimulation. As shown in Figure 2.11, Tak1 overexpression leads to robust 
phosphorylation of full length Imd, prior to PGN stimulation. 
Tak1 directly phosphorylates Imd 
In order to determine whether Tak1 is solely responsible for Imd 
phosphorylation, S2* cells were treated with dsRNA targeting two other 
downstream kinases in the Imd signaling pathway, IKKβ (encoded by ird5) or 
JNKK (encoded by hep), followed by PGN stimulation (Figure 2.12A, RNAi 
efficiency shown in figure 2.12B). Unlike Tak1, RNAi targeting JNKK only led to 
moderate decrease of Imd phosphorylation, while depletion of IKKβ failed to 
prevent it. These results demonstrate that IKKβ is not involved in this reaction, 
and JNKK may regulate it indirectly. 
 To further address whether Tak1 directly phosphorylates Imd, in vitro 
immunoprecipitation-kinase assays were performed. FLAG-tagged Tak1 WT or 
kinase dead Tak1S176A was immunoprecipitated with FLAG-agarose and used in 
a kinase reaction with recombinant SUMO-tagged Imd (or SUMO or MKK6 as 
controls) as substrates along with radiolabeled ATP (Figure 2.12C). WT Tak1 but 
not Tak1S176A phosphorylated Imd and MKK6 but not SUMO, arguing that Tak1 is 
the direct kinase of Imd. 
USP36 & Cyld deubiquitinate Imd K63 chains 
 Upon immune stimulation, Imd undergoes ubiquitin editing, during which 
the K63-polyubiquitin chains are removed and the K48-polyubiquitin are 
conjugated. USP36 and Cyld have been suggested to function as deubiquitinaing  
 
 
64
enzymes (DUB) in Drosophila (Glittenberg and Ligoxygakis, 2007, Thevenon et 
al., 2009). In order to determine whether these two DUBs target Imd for K63-
deubiquitination. S2* cells were treated with dsRNA targeting USP36 or Cyld, 
followed by PGN stimulation (Figure 2.13). Depletion of either DUBs resulted in  
accumulation of Imd K63-polyubiquitination and inhibition of K48 modification 
(Figure 2.13A, RNAi efficiency shown in figure 2.13B). Moreover, Diptericin 
induction was also up-regulated in these DUB depleted samples (Figure 2.13C). 
Together, these data demonstrate USP36 and Cyld play crucial roles in ubiquitin 
editing by removing the K63 chains. The elevated level of Diptericin suggested 
these two DUBs are also negative regulator of Imd pathway. 
2.4 Discussion 
In previous work, we demonstrated that Imd is cleaved, K63-
polyubiquitinated and phosphorylated upon immune stimulation (Paquette et al., 
2010). While this earlier study did not find K48-polyubiquitin chains, others have 
published evidence of both K63- and K48-Imd modifications (Thevenon et al., 
2009). However, the overall dynamics of and interconnections between these 
Imd post-translational modifications remained unclear. Here we show that PGN 
stimulation of S2* cells leads to five different Imd modifications proteolytic 
cleavage, K63-polyubiquitination, phosphorylation, K63-deubiquitination and 
K48-polyubiquitination, which leads to degradation of Imd through proteasome.  
These immune triggered signaling events are robust and incredibly rapid, with 
Imd cleavage and K63-polyubiquitination occurring as early as 2 minutes after 
PGN stimulation. While K63-modification peaks early and then steadily declines, 
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K48-conjugation appears later, along with phosphorylation, and declines in 
proteasome-dependent manner. These kinetics argue that Imd is sequentially 
conjugated with K63 then K48 ubiquitin, so-called ubiquitin editing, as has been 
reported for IRAK1 and RIP1 in mammalian innate immune signaling pathways 
(Newton et al., 2008).  
In addition to ubiquitination, two slow-migrating species of Imd were 
detected and shown to be phosphorylated forms.  Judging by their size, these 
two phospho-forms appear to be derived from either full-length Imd (upper) or 
cleaved Imd (lower) (Figure 2.1C). Interestingly, we also observe persistence of 
phosphorylated Imd in the proteasome-inhibited samples (Figure 2.2A), 
suggesting that Imd is both K48-polyubiquitinated and phosphorylated before 
entering proteasome. Tak1 is required for these phosphorylation events as well 
as for ubiquitin editing, demonstrating key role for this MAP3K in a negative 
feedback loop. 
 Conjugation of ubiquitin usually occurs on lysine side chains of target 
proteins, and mass spectrometry of immuno-purified endogenously expressed 
Imd identified K137 and K153 as the sites of ubiquitin linkage. Note, this mass 
spec analysis includes 50% coverage of Imd, and it remains possible that the 
other four lysines in the C-terminus could also be ubiquitinated.  On the other 
hand, substitution of K137 and K153 residue with Arginine prevented signal-
induced ubiquitination of Imd and reduced expression of the AMP gene Diptericin 
in S2* cells. These results demonstrate that both lysine residues are required for 
K63-polyubiquitination and downstream signaling events. Mutation of single 
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lysine residue led to a partial reduction of K63-ubiquitination and a partial 
reduction of AMP gene induction. Surprisingly, single lysine mutation did not 
correspondingly reduce Imd K48-polyubiquitination, while the double lysine 
mutation completely blocked it. These results suggest that even the reduced 
signal, mediated by a single K63-chain, is sufficient to trigger a robust feedback 
response with K48-chain formation, while a complete block in K63-chains 
prevents Tak1 activation, which in turn fails to promote the ubiquitin editing of 
Imd. These findings are consistent with results observed with knockdown of 
Ubc5, Ubc13 and Uev1a. Ubc5 depletion prevented all K63 ubiquitination and 
signaling (as measured by Diptericin induction), and subsequent K48 
modification was absent, while the Ubc13 and/or Uev1a knockdown showed 
residual K63 chains and greatly reduced Diptericin expression but robust K48-
ubiquitination.  These results may also suggest that K48-polyubiquitination may 
occur on other lysine residues beyond K137 and K153, although more detailed 
mass spectrometric analyses is required to map these sites more thoroughly. 
 Previous work has suggested that Diap2 is the E3 ligase for Imd 
ubiquitination (Paquette et al., 2010). With the advantage of ubiquitin linkage 
specific antibodies, data presented here show that Diap2 is required for Imd K63-
polyubiquitination and signaling, as measured by induction level of Diptericin.  
Moreover, the accumulation of cleaved but non-ubiquitinated Imd, in the Diap2 
depleted cells and flies, provides further evidence that ubiquitination is 
downstream of Imd cleavage and highlights the role of Diap2 as the critical E3 in 
the K63-modification of Imd.  In addition, Imd is no longer K48-modified when  
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Diap2 is removed, suggesting that either Diap2 is also involved in K48-
conjugation, or the failure of K63-polyubiquitination leads to the blocking of K48-
polyubiquitination.  Given the role of Tak1 in this ubiquitin editing event, we favor  
the latter hypothesis and speculate another E3 is likely involved in the K48 
conjugation. 
 In addition to E3 ligases, E2 ubiquitin conjugating enzymes are the other 
key factors in the ubiquitin conjugation reaction. We previously showed that 
Ubc5, Ubc13 and Uev1a are all involved in Imd ubiquitination (Paquette et al., 
2010). However, the mechanism by which these E2s collaborated was unclear. 
Results from in vitro reconstituted ubiquitination assays suggested a two-step 
reaction model for ubiquitin conjugation with different E2s (Christensen et al., 
2007, Rodrigo-Brenni and Morgan, 2007, Windheim et al., 2008, Williamson et 
al., 2009). In particular, it was shown that some E2s are effective at the initial 
ubiquitination of substrates but are ineffective at generating long chains, while 
other E2s are efficient at generating long ubiquitin chains but fail to conjugate 
substrate proteins.  Thus, these two sets of E2s can work together to generate 
long ubiquitin chains conjugated to target proteins. Combined with our result that 
knockdown of Ubc5 leads to complete failure of Imd polyubiquitination, we 
propose that Imd undergoes ubiquitin chain initiation and elongation catalyzed by 
two separate E2s (Figure 2.14). Once cleaved, Imd interacts with Diap2 through 
its BIR repeats and is first modified by Ubc5-mediate substrate ubiquitination on 
lysines 137 and K153. Subsequently, the E2 complex of Ubc13-Uev1a pairs with 
an E3 (possibly Diap2 although another unidentifed E3 is not excluded) and 
69
switches the reaction to chain elongation mode, during which additional ubiquitin 
molecules are attached to the substrate-linked ubiquitin in a K63-specific manner 
(Wooff et al., 2004, Andersen et al., 2005, Lamothe et al., 2007, Petroski et al., 
2007, Xia et al., 2009). In the absence of Ubc13/Uev1a, Ubc5 alone is still able to 
elongate the polyubiquitin chains with mixed linkage. 
 Induction of Diptericin expression generally tracks with the K63-
polyubiquitination signal (but not the total Ub signal) observed in various E2 
knockdown cells (Figure 2.8A, bottom panel).  The one exception is the samples 
in which Ubc13 and Uev1a are both knocked down, and Ubc5 is still available. 
These samples display a similar K63 intensity as the single Ubc13 or Uev1a 
RNAi lanes, but Diptericin induction is lower, close to background levels. Ubc5 
alone is known to conjugate ubiquitin without linkage specificity, a random 
polyubiquitin chain that consist of all seven types lysine linkage (Windheim et al., 
2008). Since the K63 antibody recognizes K63-linked diubiquitin (Newton et al., 
2008), it is possible that Ubc5-mediated random ubiquitin chain elongation 
generates some K63 di-ubiquitin linkages which are detected by this antibody, 
but they don’t support signaling due to their altered topology and limited amounts 
of K63-linkages.  More detailed biochemical characterization of these Ubc5-
catalyzed chains is required to confirm this hypothesis. 
 K48 modification of Imd shows a subtle difference relative to the K63 
chains.  Again, knock down of Ubc5 causes complete blocking of K48 
conjugation, but depletion of Ubc13/Uev1a has no effect. The failure of K48 
modification in the Ubc5 depleted cells may have two possible underlying 
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causes.  Firstly, the complete lack of K63 chains will fail to activate Tak1 and the 
subsequent ubiquitin editing feedback loop, while the Ubc13 and/or Uev1a 
display some residual activity and thus can trigger Tak1 and the feedback 
response.  Alternatively, Ubc5 might be directly required for Imd K48-
polyubiquitination as shown in the degradation of proteins in multiple Drosophila 
pathways including eye development (Dickson, 1998, Wu et al., 1999), 
maintenance of germline stem cells (Chen et al., 2009) and apoptosis 
(Bergmann, 2010).  These are not mutually exclusive possibilities. 
 Phosphorylation of Imd appears to be a major regulator of these ubiquitin-
editing events.  Knockdown of Tak1 prevents Imd phosphorylation in S2* cells 
and in adult flies.  Moreover, immune-purified Tak1 can directly phosphorylate 
recombinant Imd in vitro, while neither JNKK nor IKK are required for Imd 
phosphorylation, strongly arguing that Tak1 directly modifies Imd.  RNAi-
depletion or drug inhibition of Tak1 prevents K63-deubiquitination and the 
subsequent K48-polyubiquitination/proteasome-mediated degradation, leading to 
accumulation of cleaved but unphosphorylated Imd, presumably an intermediate 
during chain editing.  From these results, we infer that Tak1-mediated 
phosphorylation of Imd is required for ubiquitin editing. So far, I haven’t been able 
to map the phosphorylation sites on Imd and directly connect the ubiquitin-editing 
with phosphorylation events. Future studies will reveal the underlying 
mechanisms by which phosphorylation triggers K63-deubiquitination and K48 
chain conjugation.  Nonetheless, these results are consistent with earlier reports 
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of Imd regulation by K63-deubiquitination and degradation (Thevenon et al., 
2009). 
 USP36 and Cyld have been suggested to function as deubiquitinating 
enzyme in Drosophila (Glittenberg and Ligoxygakis, 2007, Thevenon et al., 
2009). With the advantage of linkage specific ubiquitin antibodies, the data 
presented here show both USP36 and Cyld remove K63 chains from Imd, a key  
step during ubiquitin chain editing that results in conjugation of K48 ubiquitin and 
proteasome mediated degradation. K63-polyubiquitin chains have been 
demonstrated as signaling activating factor that leads to induction of AMPs such 
as Diptericin. Removal of K63 ubiquitin by these two DUBs blocks the signal 
transduction and thus down-regulates NF-κB pathway activation, a crucial 
mechanism preventing unnecessary or prolonged innate immune response. 
 Considering the results presented here together with earlier studies, we 
propose the following model of Imd signal activation and subsequent down-
regulation (Figure 2.14).  One of the earliest events after PGN-stimulation is the 
rapid cleavage of Imd by the caspase-8 homolog DREDD at D30 (Paquette et al., 
2010). Cleaved Imd then interacts with BIR-repeats of the E3 ligase Diap2 and is  
K63-polyubiquitinated through the action of Ubc5 for substrate conjugation and 
Ubc13-Uev1a, for catalyzing long K63 chains. These K63-polyubiquitin chains 
are then likely to activate the Tak1/Tab2 kinase complex through the conserved 
K63-binding motif in Tab2, which in turns signals through IKK complex to activate 
the NF-κB precursor Relish (Erturk-Hasdemir et al., 2009).  Relish is central for 
the robust induction of AMP gene transcription. Meanwhile, Tak1 also mediates a  
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retrograde signal that phosphorylates Imd and triggers ubiquitin editing, and 
leads to the degradation of Imd through proteasome. This regulatory interaction 
between Tak1 and Imd represents a novel negative feedback loop whereby the 
Drosophila immune response is rapidly activated but also quickly shutdown. 
Future studies are necessary to determine function of this feedback loop relative 
to other feedback mechanisms reported for the Imd pathway (Khush et al., 2002, 
Werner et al., 2003, Kaneko et al., 2004, Kim et al., 2006, Lhocine et al., 2008, 
Kleino et al., 2008, Aggarwal et al., 2008, Guntermann et al., 2009, Basbous et 
al., 2011). 
2.5 Materials and methods 
Fly stocks 
 The following fly strains were used in this work: w1118, Diap27c (Leulier et 
al., 2006), imd10191 (Pham et al., 2007), yw;wt and yw;Tak12 (Vidal et al., 2001). 
Antibodies 
 Anti-K63 (Apu3) and anti-K48 (Apu2) ubiquitin antibodies were purchased 
from EMD MILLIPORE (Billerica, MA, USA). Total ubiquitin antibody (P4D1) was 
purchased from Santa Cruz Biotechnology (Dallas, Texas, USA). Anti-FLAG M2 
Affinity Gel and anti-FLAG antibody were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). Polyclonal Imd antibody was prepared by immunizing rabbits 
with peptide (31-AAPVDDNEPDN-41) according to the affinity-purified package 
offered by New England Peptide (Gardner, MA, USA). 
Peptidoglycan preparation 
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 5-liter culture of E. coli strain 1106 was collected and re-suspended with 
4% SDS solution before boiling at 100°C for 30 minutes. Traces of SDS were 
removed by repeating centrifugation and re-suspending with sterilized water. 
Then the lysate was sequentially treated with DNase, α-amylase and pronase. 
These enzymes were removed by repeating centrifugation and re-suspending 
with sterilized water. At last the lysate was treated with sonification and 
lyophilization, and prepared as 1mg/ml stock. 
Immunoprecipitation and immunoblotting protein assay 
 Cells or flies were lysed in standard lysis buffer containing 10% glycerol, 
1% Triton X-100, 20mM Tris, 150mM NaCl, 24mM β-glycerolphosphate, 2mM 
EDTA, 1mM DTT, 1mM Sodium Orthovanadate, 5mM NEM, 1X Protease 
Inhibitor Cocktail. Total protein lysates was immunoprecipitated overnight at 4°C 
followed by immunoblotting at room temperature. 
Ubiquitination assay 
Cells or flies were lysed in denaturing lysis buffer (1% SDS mixed with standard 
lysis buffer) and then incubated at 100°C for 10minutes. Lysates was diluted 10 
fold with standard lysis buffer (without 1% SDS) before immunoprecipitation 
overnight at 4°C followed by immunoblotting at room temperature. 
Proteasome inhibition assay 
S2* cells were treated with 20-hydroxyecdysone (1µM) for 24 hours before 
treatment of 10µM MG-132 (Sigma-Aldrich, St. Louis, MO, USA) for 6 hours, 
followed by PGN stimulation and protein assay. 
λ-phosphatase assay 
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 S2* cells were stimulated with E. coli PGN for indicated times, before lysis. 
The whole cell lysates (100ng for each condition) was treated without or with λ-
phosphatase for 30 minutes at 30°C, followed by immunoblotting with anti-Imd. 
Protein purification for Mass-Spectrometry 
 S2* cells were stimulated with PGN for 0 and 15 minutes, before lysed 
with lysis buffer as described above. 20mg of total protein lysate was 
immunoprecipitated overnight at 4°C with anti-Imd. Samples were washed twice 
with 5ml lysis buffer and eluted with 200µl elution buffer (1M citric acid pH 2.2). 
Elutes were separated by SDS-PAGE and stained by Coomassie Blue. The 
corresponding bands were cut out for in gel trypsin digestion, and analyzed by 
tandem mass spectrometry. 
In Gel Digestion (MS) 
Gel slices were cut into 1x1 mm pieces and placed in 1.5ml eppendorf tubes with 
1ml of water for 1 hr.  The water was removed and 50 µl of 250 mM ammonium 
bicarbonate was added.  For reduction 5 µl of a 45 mM solution of 1, 4 
dithiothreitol (DTT) was added and the samples were incubated at 50 C for 30 
min.   The samples were cooled to room temperature and then for alkylation 5 µl 
of a 100 mM iodoacetamide solution was added and allowed to react for 30 min.  
The gel slices were washed 2 X with 1 ml water aliquots.  The water was 
removed and 1ml of 50:50 (50mM Ammonium Bicarbonate: Acetonitrile) was 
placed in each tube and samples were incubated at room temperature for 1hr.  
The solution was then removed and 200 µl of acetonitrile was added to each tube 
at which point the gels slices turned opaque white.  The acetonitrile was removed 
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and gel slices were further dried in a Speed Vac.  Gel slices were rehydrated in 
50µl of 2ng/µl trypsin (Sigma) in 0.01% ProteaseMAX Surfactant (Promega): 
50mM Ammonium Bicarbonate.  An additional aliquot of 50 mM Ammonium 
Bicarbonate was added to fully submerge the gel slices. Samples were incubated 
at 37C for 21hrs. The supernatant of each sample was then removed and placed 
in a separate 1.5 ml eppendorf tube.  Gel slices were further dehydrated with 100 
µl of 80:20 (Acetonitrile: 1% formic acid).  The extract was combined with the 
supernatants of each sample. The samples were then dried down in a Speed 
Vac (Savant Instruments, Inc.).   
LC/MS/MS on Orbitrap Velos 
  Tryptic peptides were dissolved in 20 µl of 0.1% TFA and a 3.5 µl aliquot was 
directly injected onto a custom packed trap column (2cm x 100um C18).  
Peptides were then eluted and sprayed from a custom packed emitter (75µM x 
25cm C18) with a linear gradient from 100% solvent A (0.1% formic acid in 5% 
Acetonitrile) to 35% solvent B (0.1% formic acid in Acetonitrile) in 90 minutes at a 
flow rate of 300 nanoliters per minute on a Proxeon Easy nanoLC system directly 
coupled to a LTQ Orbitrap Velos mass spectrometer (Thermo Scientific).  Data 
dependent acquisitions were set up according to an experiment where full MS 
scans from 350 -2000 m/z were acquired in the Orbitrap at a resolution of 60000 
followed by 10 MS/MS scans acquired in the LTQ ion trap instrument.  
Data Analysis (MS) 
 The raw data files were processed with Proteome Discoverer v. 1.3 (Thermo 
Scientific) into peak lists and then searched against the Drosophila Index of the 
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UniProt database using the Mascot Search engine ver. 2.3 (Matrixsciences, Ltd.).   
Parent mass tolerances were set to 10 ppm and fragment mass tolerances were 
set to 0.5 Da.  The variable modifications of acetyl (protein N-term), GG on 
Lysine, pyro glutamic for N-term glutamine, carbamidomethylation of cysteine 
and oxidation of methionine were used. Mascot search results were loaded into 
the Scaffold software (Proteome Software, Inc.) to compare sample results. For 
quantitative analysis of the ubiquinated peptides of ubiquitin the Skyline software 
v 2.6 (University of Washington) was used to extract precursor ion 
chromatograms. 
RNAi 
 DsRNA was produced using T7 RiboMAX Express Large Scale RNA 
Production System (Promega). S2* cells were split to 0.5*106 cells/ml and 
incubated for ~24 hours at 27°C. 2µg/ml dsRNA was delivered by calcium 
phosphate transfection and cells were allowed to recover for 18 hours at 27°C. 
1µM 20-hydroxyecdysone was then added to the cells for 24 hours. Finally cells 
were treated with peptidoglycan (10µg/ml), before harvesting for experiments. 
Imd lysine mutants assay 
 Stable cell line expressing FLAG-Imd WT, K137R, K153R or K137/153R 
were generated and then transfected with dsRNA targeting Imd 3’-UTR to 
knockdown the endogenous Imd. Cells were allowed to recover for 18 hours at 
27°C before treatment of 20-hydroxyecdysone (1µM). Finally cells were 
stimulated with peptidoglycan (10µg/ml) and harvested for experiments. 
E2 RNAi 
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Each sample is transfected with 10ug dsRNA per target gene, and the 
total dsRNA used in each sample is equalized to 30ug by adding GFP dsRNA. 
Cells were allowed to recover for 18 hours at 27°C before treatment of 20-
hydroxyecdysone (1µM). Finally cells were stimulated with peptidoglycan 
(10µg/ml) and harvested for experiments. 
RNA analysis 
 Total RNA was extracted with TRIzol (Invitrogen), treated with DNase I 
and purified by phenol/chloroform. Transcripts from gene of interest were 
monitored by qRT-PCR (Bio-Rad, Hercules, California, USA). Gene expression 
level in each sample was normalized with RP49. Data from 3 biological 
independent experiments were collected, normalized with control samples and 
plotted as mean ± SD (standard deviation). 
Tak1 inhibitor assay 
 S2* cells were treated with 20-hydroxyecdysone (1µM) for 24 hours before 
treatment of 2µM 5Z-7-Oxozeaenol (Sigma-Aldrich, St. Louis, MO, USA) for 3 
hours, followed by PGN stimulation and protein assay. 
Kinase assay 
 Recombinant proteins 6xHIS-SUMO-Imd(31-273), 6xHIS-SUMO and 
6xHIS-MKK6-K28A were purified with Nickel Magnetic Beads (EMD MILLIPORE, 
Billerica, MA, USA). Stable cell lines expressing Flag-tagged Tak1 WT or S176A 
(kinase dead) from the Cu2+ inducible metallothionein promoter were treated with 
CuSO4 (500µM) for 6 hours before lysing with lysis buffer as described above. 
100-400ng of total protein lysate from each cell lines was immunoprecipitated 
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with anti-Flag for 2 hours at 4°C. Kinases were then washed twice with 500µl 
lysis buffer and twice with 500µl kinase buffer (200mM HEPES, 200mM β-
glycerolphosphate, 100mM MgCl2, 500mM NaCl, 10mM DTT, 1mM Sodium 
Orthovanadate, 1µM Okadaic acid). Finally, kinases were incubated in kinase 
buffer containing 200µM cold ATP, 5µCi γ-32P-ATP, and with substrate (100ng 
each) at 30°C for 30 minutes. Samples were separated by SDS-PAGE, fixed with 
10% methanol/10% acidic acid, dried and autoradiographed. 
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3.1 Abstract 
 Ubiquitination plays a central role in signaling transduction of NF-κB 
pathway in both mammals and insects. Characterization of ubiquitin conjugation 
on substrate protein is crucial for understanding the mechanism of signaling 
modulation by polyubiquitin chains and its associated partners. Previously, cell 
culture based Mass spectrometry and biochemistry assays indicate Imd lysine 
residues 137 and 153 are required for conjugation of polyubiquitin chains and 
signaling measured by induction of Diptericin. However, it is still unknown 
whether these two residues play similar roles in flies. Here, we demonstrate that 
the results from transgenic rescue analysis indicate both lysine 137 and 153 are 
critical for Imd ubiquitination and expression of Diptericin in vivo, whereas 
CRISPR-mediated gene editing analysis fails to produce Imd protein, leading to 
total block of Diptericin induction. 
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3.2 Introduction 
 The Imd signaling is one of the two major immune-responsive NF-κB 
activating pathways in Drosophila. Triggered by DAP-type peptidoglycan from 
cell wall of Gram-negative bateria, this signaling cascade leads to robust 
induction of antimicrobial peptides (AMPs) (Ferrandon et al., 2007, Lemaitre and 
Hoffmann, 2007). Ubiquitination of Imd, a receptor-proximal adaptor protein 
homologous to mammalian RIP1, plays a central role in signal transduction from 
recognition of bacteria derivatives to activation of NF-κB protein Relish and 
induction of immune-responsive genes. In previous chapter, we demonstrated 
that in Drosophila S2 cell, Imd lysine residues 137 and 153 are required for 
conjugation of K63-linked polyubiquitin chains and signaling activation, as 
measured by induction of Diptericin. However, it is still unclear whether flies 
exploit these two residues as ubiquitin conjugation sites. To address this 
question, we utilized two different approaches, PhiC31 integrase-mediated 
transgenesis and CRISPR-mediated gene editing, to explore the genetic 
outcome caused by substitution of these residues with arginine. 
 The ability to introduce and control the expression of transgenes in 
Drosophila is a powerful tool for understanding how genes function. Introduced in 
the early 1980s (Rubin & Spradling, 1982), P-element technique, combined with 
the Gal-4/UAS binary system (Brand & Perrimon, 1993), allowed researchers to 
examine the consequences of gene over-expression in a specific set of tissues or 
cells. However, the featured characteristic of P-elements, random integration, is 
generally not ideal for transgene analysis. Strategies have been developed to 
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circumvent the problem of randomness by targeted integration systems, such as 
Flipase recombination enzyme/Flipase Recognition Target (FLP/FRT) system 
(Xu & Rubin, 1993), and PhiC31 integrase-mediated transgenesis (Groth et al., 
2004), which allows for integration of plasmid DNA at a site-specific location, 
resulting in robust and long-term transgene expression. bacteriophage PhiC31 
integrase mediates sequence-directed, irreversible integration between a 
bacterial attachment site (attB) and a phage attachment site (attP). Injection of 
plasmid containing attB site and screen marker into strains with attP docking site 
and PhiC31 activity makes stable transformants containing your gene-of-interest 
and screen marker. 
Comparing site-specific transgene expression, targeted genome editing 
using customized nucleases provides a method to introducing deletions, 
insertions and substitution at the original locus. The first step for performing site-
specific gene editing is the introduction of a DNA double-stranded break (DSB) at 
the locus of interest (Carroll, 2011). Nuclease-induced DSBs can be repaired by 
non-homologous end-joining (NHEJ) and homology-directed repair (HDR). NHEJ 
can lead to deletion mutations, which can disrupt the translational reading frame 
of a coding sequence or the binding sites of trans-acting factors in promoters or 
enhancers. HDR-mediated repair is efficient to introduce point mutations or 
insertion through recombination of the target locus with foreign donor DNA 
templates. Early strategies for targeting nuclease-induced DSB to specific 
genomic location relied on protein-based systems with customizable DNA-
binding specificities, such as zinc finger nucleases (ZFNs) and transcription 
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activator–like effector nucleases (TALENs). Recently, a platform based on 
CRISPR (clustered, regularly interspaced, short palindromic repeat) and its 
associated nucease Cas9 has been developed (Sander & Joung, 2014). CRISPR 
system is used by bacteria to protect themselves against foreign nucleic acids 
originated from viruses (Barrangou et al., 2007, Wiedenheft et al., 2012, Fineran 
& Charpentier, 2012). CRISPR incorporates invading DNA sequence and the 
transcripts from CRISPR are processed and complex with the Cas9 nuclease, 
which cleave complementary foreign DNA. The most crucial step in CRISPR-
mediated gene editing is the generation of DSB by proper guide RNA (gRNA). 
The gRNA contains a 20-nucleotide region that is complementary to the target 
DNA site, immediately followed by a PAM sequence with the canonical form of 
5’-NGG (Jinek et al., 2012, Jiang et al., 2013). After the initial characterization of 
CRISPR, this platform has been demonstrated as an efficient tool in a variety of 
cells and organisms including Drosophila (Yu et al., 2013, Bassett et al., 2013). 
3.3 Results 
PhiC31 integrase mediated transgenic rescue  
To completely include the Imd and its regulatory unit located upstream and 
downstream, about 3kb of extended gene region was cloned into pattB vector 
(Figure 3.1A, within 5’ and 3’ primers). Lysine residues 137 and 153 are 
substituted with Arginine individually, or in combination, generating four donor-
plasmids: pattB-WT, -K137R, -K153R and –K137/153R. Flies injected with these 
donors were crossed with double balancer and Imd null allele imd10191, as 
outlined in Figure 3.1B, and homozygous flies were collected for experiments.  
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Only double lysine mutation failed to complement the imd10191 null mutant, 
preventing Imd ubiquitination in response to E. coli septic infection (Figure 3.2A). 
Similarly, the signaling pathway activity, as measured by induction of the 
antimicrobial peptide gene Diptericin, showed approximately 50%  
reduction by double lysine mutation (Figure 3.2B). Unlike S2 cell based assays in 
previous chapter, single lysine substitution still exhibited comparable amount of 
ubiquitination and Diptericin expression, relative to WT. These results 
demonstrate that ubiquitination at K137 and K153 is also involved in Imd 
signaling in Drosophila. 
CRISPR-Cas9 mediated gene editing 
 To further examine the importance of these lysine residues in vivo, 
CRISPR-Cas9 mediated gene editing was done to introduce lysine substitution 
with Arginine at the original locus. Flies carrying the Cas9 transgene were 
injected with gRNA and donor DNA plasmid containing desired mutation 
(K137/153R) and a silent mutation creating an additional SacII restriction 
digestion site (Figure 3.3A). Injected flies were crossed with balancer to maintain 
stable stains during genotyping screen. Progenies from five injected flies were 
genotyped by restriction digestion and sequencing, generating 9 strains 
homozygous with double lysine mutation (Figure 3.3B). Although both the Imd 
genomic locus and cDNA from the transcripts were confirmed by sequencing, 
none of these 9 strains exhibit any sign of Imd protein production, leading to 
complete block of Diptericin induction (Figure 3.4). 
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3.4 Discussion 
 In previous chapter, we demonstrated that ubiquitination at K137 and 
K153 is critical for Imd signaling in Drosophila S2 cell. Here, we used two 
different approaches to validate the importance of lysine 137 and 153 in vivo. 
The overall effect caused by substitution of lysine residues in transgenic flies is 
less dramatic comparing to what we observed in S2 cell. Particularly, either  
single lysine mutation is still able to complement the imd10191 null mutant, as 
shown by the comparable level of Imd total ubiquitination and Diptericin 
induction. Moreover, substitution of both lysine residues effectively prevented  
Imd polyubiquitination, whereas Diptericin induction is only moderately inhibited 
(about 50%). The pattern of ubiquitination in the absence of each lysine residue 
suggests the possibility of ubiquitin conjugation at alternative sites. Recent study 
demonstrated ubiquitination could occur on lysine-less TRIM21, in which all 
lysine residues are substituted with arginine (Fletcher et al., 2015). The Diptericin 
expression profile suggests that activation of NF-κB protein Relish and its 
transcriptional target do not solely rely on ubiquitination of Imd. The ubiquitination 
of the upstream caspase Dredd has been shown to be critical for signaling 
(Meinander et al., 2012). This redundancy may represent multiple parallel 
mechanisms that contribute to the NF-κB activation. Furthermore, tissue specific 
immune response may explain the difference of Diptericin induction between 
macrophage-derived S2 cells and whole flies, in which fat body, instead of 
hemocyte, is the major organ for production of AMPs.  
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 Besides ubiquitination and Diptericin induction, immunoblot against Imd 
done in transgenic flies shows significant difference of Imd signal intensities 
among those samples (Figure 3.2A), and this phenomenon is only observed with 
these transgenic strains. Judging by the similar amount of cleaved Imd in those 
E. coli infected samples, this discrepancy is most likely a technical artifact 
instead of indication of actual protein level. The antibody may exhibit distinct 
affinities towards different forms of Imd protein extracted from the whole animals. 
Further experiments are required to elucidate this issue. 
 Surprisingly, CRISPR-mediated Imd gene editing shows a total absence of 
protein production, although nucleotide sequences of both Imd genomic locus 
and cDNA synthesized from RNA transcripts are proved correct. Combination of 
these two pieces of evidence above suggests that substitution of both lysine 
residues may affect the stability of the Imd protein, such as misfolding due to 
residue change, leading to intrinsic protein degradation mechanism through 
proteasome. More experiments are necessary to clarify this possibility. 
3.5 Materials and methods 
Cloning of donor plasmid for PhiC-31 mediated Imd transgenic rescue 
Primer sequences: 
5’-ACACCAGCGGCCGCCGCCGTCCGTGTGTATTATC 
3’-CACCTAGGTACCAACCATCGCCGACTACAGTG 
Genotyping of PhiC-31 mediated Imd transgenic rescue strains 
Primer set for genotyping of Imd null background: 
5’-TTGTGACTGTGTGGGTGAGC 
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3’-ATTCGGTCAGATCCGAGGAG 
3’-AAGTGCGTGGAAACCACATC 
Primer set for genotyping of transgene: 
5’-CGGGAATTGGGAATTCGTT 
3’-AAGTGCGTGGAAACCACATC 
Fly stocks 
 The following fly strains were used in this work: w1118, imd10191, w; Bl/Cyo; 
TM2/TM6b, w; Bl/Cyo. 
Antibodies 
 Total ubiquitin antibody (P4D1) was purchased from Santa Cruz 
Biotechnology (Dallas, Texas, USA). Polyclonal Imd antibody was prepared by 
immunizing rabbits with peptide (31-AAPVDDNEPDN-41) according to the 
affinity-purified package offered by New England Peptide (Gardner, MA, USA). 
Immunoprecipitation and immunoblotting protein assay 
 Flies were lysed in standard lysis buffer containing 10% glycerol, 1% 
Triton X-100, 20mM Tris, 150mM NaCl, 24mM β-glycerolphosphate, 2mM EDTA, 
1mM DTT, 1mM Sodium Orthovanadate, 5mM NEM, 1X Protease Inhibitor 
Cocktail. Total protein lysates was immunoprecipitated overnight at 4°C followed 
by immunoblotting at room temperature. 
RNA analysis 
 Total RNA was extracted with TRIzol (Invitrogen), treated with DNase I 
and purified by phenol/chloroform. Transcripts from gene of interest were 
monitored by qRT-PCR (Bio-Rad, Hercules, California, USA). Gene expression 
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level in each sample was normalized with RP49. Data from 3 biological 
independent experiments were collected, normalized with control samples and 
plotted as mean ± SD (standard deviation). 
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Chapter IV:  
Conclusion & Discussion
95
 The research undertaken in this thesis is focused on understanding the 
molecular mechanisms of innate immune signal transduction in the Drosophila 
Imd pathway, in particular signaling modulation by post-translational 
modifications. This work demonstrates that ubiquitin-editing plays a central role in 
the Imd pathway through polyubiquitination mediated up- and down-regulation of 
signaling. This mechanism provides immediate control over signal transduction at 
the protein level within minutes upon infections, whereas expression of signaling 
modulators induced by transcription factors takes hours. 
 Polyubiquitination has been suggested to play a critical role in the 
Drosophila Imd signaling pathway for some time. Since the identification of the 
E2 ubiquitin conjugating enzyme complex Uev1a/Ubc13 (Bendless) (Zhou et al., 
2005), a number of groups showed that the IAP protein and putative E3 ligase 
DIAP2 play an important role in Imd signaling (Gesellchen et al., 2005, Kleino et 
al., 2005, Leulier et al., 2006, Huh et al., 2007). Recent work from our lab 
demonstrated that Imd is K63-polyubiquitinated by E3 ligase Diap2 and E2 
ubiquitin conjugating enzyme Ubc5 (Effete) and Uev1a-Ubc13. Furthermore, this 
ubiquitination event is essential for activation of downstream kinase Tak1 and 
expression of NF-κB target genes, such as Diptericin (Paquette et al., 2010).  
 Ubiquitination plays a crucial role in mammalian innate immune signaling. 
Activation of TLRs, TNFR, or IL-1R lead to the K63-polyubiquitination of various 
adaptor proteins such as RIP1, RIP2, TRAF2 and TRAF6. K63-polyubiquitination 
of these proteins is, in most cases, mediated by the mammalian Ubc13-Uev1a 
E2 complex.  Unlike K48-polyubiquitination which leads to proteasome mediated 
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degradation, K63-modification is considered as a scaffold for downstream 
members of the signaling pathway. For example, MAP3 kinase Tak1 is recruited 
by the association of K63-polyubiquitin chains and ubiquitin binding domains 
(UBDs) found in its binding partner TAB2/3 (Wang et al., 2001, Zhou et al., 
2005).   
In concert with the Ubc13-Uev1a E2 complex, RING E3 ligases TRAF2 
and TRAF6 were though to catalyze the conjugation of K63-polyubiquitin chains.  
Recent studies in TNF signaling showed IAP proteins cIAP1 and cIAP2, instead 
of TRAF2, were identified as the RIP1 E3 ligases (Bertrand et al., 2008). 
Moreover, the activation of IKK in this pathway is dependent of Ubc5 rather than 
Ubc13-Uev1a mediated K63 polyubiquitination. Similarly, the Drosophila Imd 
signaling, a TNF-like pathway, utilizes IAP protein Diap2 as the E3 ligase to 
ubiquitinate RIP1 homologue Imd with both Ubc5 and Ubc13-Uev1a. 
Analysis of the role of ubiquitination in a less complex model system like 
Drosophila may help clarify the molecular mechanisms of innate immune 
signaling modulation. The work presented in Chapter 2 illustrates that upon PGN 
stimulation, the adaptor protein and mammalian RIP1 homologue Imd undergoes 
a series of sequential post-translational modification. It is rapidly cleaved and 
conjugated with K63-linked polyubiquitin chains. It is still unclear that how Imd 
polyubiquitination leads to activation of downstream kinase Tak1. Preliminary 
data in our lab showed that the NZF domain, which is a ubiquitin binding domain 
(UBD) in the Tab2, associates with K63 chains in vitro, suggesting the 
transduction of signal by recruitment of Tak1 to the polyubiquitin chains 
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conjugated on Imd. Activated Tak1 signals through IKK complex and NF-κB 
protein Relish, leading to induction of AMP genes. Meanwhile, activated TAK1 
functions in a feedback loop by directly phosphorylating Imd, promoting Imd K63-
deubiquitination and K48-polyubiquitination, finally leading to degradation of Imd. 
 Mass-spectrometry analysis identified two lysine residues on Imd, K137 
and K153, are target sites for ubiquitin conjugation. Substitution of these lysine 
residues with arginine resulted in little or no Imd K63-polyubiquitination, both in 
S2* cells and adult flies, while AMP induction was significantly reduced. These 
results demonstrate that K137 and K153 are required for ubiquitin conjugation of 
Imd and are important for signaling in Drosophila S2 cell. However, The overall 
effect caused by substitution of lysine residues in transgenic adult flies is less 
dramatic comparing to what we observed in S2 cell. Particularly, either single 
lysine mutation was still able to complement the imd10191 null mutant, as shown 
by the comparable level of Imd total ubiquitination and Diptericin induction. 
Moreover, substitution of both lysine residues effectively prevented Imd 
polyubiquitination, whereas Diptericin induction was only moderately inhibited 
(about 50%). The pattern of ubiquitination in the absence of each lysine residue 
suggests the possibility of ubiquitin conjugation at alternative sites. Recent 
reports demonstrated ubiquitination could occur on lysine-less TRIM21, in which 
all lysine residues are substituted with arginine (Fletcher et al., 2015). The 
Diptericin expression profile suggests that activation of NF-κB protein Relish and 
its transcriptional target do not solely rely on ubiquitination of Imd. The 
ubiquitination of the upstream caspase Dredd has been shown to be critical for 
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signaling (Meinander et al., 2012). The E3 ligase Diap2 itself is also 
polyubiquitinated upon immune stimulation (Paquette et al., 2010). This 
redundancy of NF-κB activation by parallel ubiquitination events, combined with 
the initial observation that Imd null mutant results in total block of Diptericin 
expression, implies that activation of this pathway triggers formation of a 
cytosolic complex including Imd, Diap2 and Dredd. Similar to the RIP1/TRAFs 
complex in mammalian NF-κB signaling, this complex undergoes extensive 
polyubiquitination on multiple substrate proteins, leading to activation of 
downstream kinases and Relish. Absence of any one of these binding partners 
will disrupt the complex and block the signaling. To verify this hypothesis, three 
questions need to be answered: what is the dynamics of complex formation, how 
do these proteins interact with each other, and how does each of them activate 
downstream signaling through polyubiquitin chains. On the other hand, tissue 
specific immune response may explain the difference of Diptericin induction 
profile between macrophage-derived S2* cells and whole flies, in which fat body, 
instead of hemocyte, is the major organ for production of AMPs. To elucidate this 
possibility, UAS/GAL4 binary system is a potentially viable approach. Over-
expression of Imd with hemocyte-specific GAL4 drivers in an Imd null mutant 
background will limit the induction of Diptericin in the hemocyte instead of fat 
body. Thus, direct comparison can be made between tissue culture cells and 
whole animals. 
Unlike K63-polyubiquitination, Imd K48-modification seemed unaffected 
when either lysine is singly mutated, except when both lysine residues were 
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replaced with arginine. Although K48 conjugation may target the same residues, 
we favor the hypothesis that prevention of K63-polyubiquitination by double 
lysine mutation results in failure of Tak1 activation and subsequent ubiquitin 
editing, which switches the K63- with K48-modification. On the other hand, single 
lysine mutation is still able to generate K63 chains sufficient to drive signal 
transduction, leading to conjugation K48 chains.  
To identify the lysine residues utilized by K48 conjugation, I propose an 
assay similar to the methods used for characterization of K63 ubiquitination sites. 
Mass-spectrometry has been proved as a useful tool for this purpose. To 
eliminate unwanted ubiquitin types, such as K63 chains, a sequential purification 
against Imd and K48 ubiquitin will be able to enrich the K48-modified Imd from 
total cell lysate. Alternatively, treatment of proteasome inhibitor MG-132 is also a 
potentially viable option for enrichment of K48-ubiquitinated Imd. Once the MS 
analysis provides me with lysine candidates of K48 conjugation, cell line and 
animal based lysine substitution assay can be informative to validate the results. 
 Further analysis showed Imd K63-polyubiquitination is achieved by E3 
ligase Diap2 and two E2 ubiquitin conjugating enzyme, Ubc5 (Effete) and Ubc13 
(Bendless)-Uev1a, in a two-step manner. Ubc5 first catalyze the initiation step by 
conjugation of mono-ubiquitin. Ubc13-Uev1a then replaces Ubc5 and start the 
chain elongation with K63 linkage. Without Ubc5, Ubc13-Uev1a fails to initiate 
the reaction, possibly because of missing anchor point (mono-ubiquitination), 
whereas Ubc5 alone is still able to initiate and elongate the polyubiquitin chains 
with unknown linkage. The pathway activation level measured by Diptericin 
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induction is relatively proportional to the intensity of Imd K63-polyubiquitination, 
except when Ubc13/Uev1a is knocked down and Ubc5 is the only E2 available. 
Ubc5 is known to catalyze polyubiquitin chains with mix/random linkage 
(Windheim et al., 2008). This type of topology may still be recognized by K63-
specific antibody, which is designed to target K63-linked di-ubiquitin. However, 
these random linkages would be predicted to fail to induce NF-κB target genes 
due to their inability to recruit downstream factors through linkage-specific 
ubiquitin binding domain (UBD).  
 On the other hand, Imd K48-polyubiquitination seems to be Ubc13-Uev1a 
independent, while the failure of K48 modification in the Ubc5 depleted cells may 
have two possible underlying causes. The complete lack of K63 chains fails to 
activate Tak1-mediated feedback loop that results in K48 conjugation, whereas 
the Ubc13 and/or Uev1a RNAi display some residual activity and thus can trigger 
Tak1 and the feedback response. Alternatively, Ubc5 may be directly required for 
Imd K48-polyubiquitination as shown in the degradation of proteins in multiple 
Drosophila pathways including eye development (Dickson, 1998, Wu et al., 
1999), maintenance of germline stem cells (Chen et al., 2009), and apoptosis 
(Bergmann, 2010), or the complete lack of K63 chains fails to activate Tak1-
mediated feedback loop including K48 conjugation.  
Ubc5, coordinated with E3 ligaseTRAF6, has also been shown to produce 
polyubiquitin chains that are not conjugated to any target proteins in mammals. 
These unanchored K63-polyubiquitin chains were found to directly activate the 
TAK1 kinase through association with TAB2/TAB3, leading to activation of IKK 
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complex (Xia et al., 2009). Thus the mere presence of polyubiquitin chains, not 
the target to which they are bound, may be important for activation of these 
kinases. Currently, no evidence implicates the existence of unanchored chains in 
Drosophila. The participation of Ubc5 in Imd polyubiquitination suggests the 
possibility that this unique type of ubiquitin chains may also play a role in the Imd 
signaling. 
Lately, a novel type of polyubiquitination, linear polyubiquitin chains, has 
been demonstrated to play a critical role, similar but non-redundant to K63 
chains, in mammalian innate immune signaling pathway (Rahighi et al., 2009, 
Haas, 2009). In TNF signaling, NEMO contains two ubiquitin binding domains 
(UBD), a zing finger type UBD that binds K63 polyubiquitin chains and a coiled–
coil UBD called UBAN (ubiquitin binding in ABIN and NEMO) that specifically 
binds linear polyubiquitin chains (Komander et al., 2009, Laplantine et al., 2009, 
Lo et al., 2009, Yoshikawa et al., 2009). However, full length NEMO preferentially 
binds linear chains over K63 polyubiquitin chains (Rahighi et al., 2009), and 
NEMO mutants that fail to bind linear Ub are unable to complement NEMO 
knockout cells. Moreover, NEMO also gets conjugated with linear Polyubiquitin 
by E3 ligase LUBAC (Linear Ub Assembly Complex), which is known to only 
generate linear chains. LUBAC is consist of two RING finger proteins: HOIL–1L 
(heme–oxidized iron–regulatory protein 2 ubiquitin ligase 1) and HOIP (HOIL–
1L–interacting protein) (Kirisako et al., 2006). The fact that LUBAC only 
participates in linear chains formation, with cooperation of several different E2 
enzymes such as UbcH5, E2–25K and UbcH10, suggest that the E3 ligase, 
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instead of E2 ubiquitin conjugating enzyme, determines the synthesis of linear 
polyubuqiutin chain (Kirisako et al., 2006, Haas, 2009). Currently, Drosophila 
homologue of LUBAC has been identified, but no evidence implicates the 
existence of linear chains in Drosophila innate immunity. 
 Besides ubiquitination, Imd is also undergoes phosphorylation in a 
stimulation dependent manner. TAK1 not only directly phsophorylates Imd, but 
also triggers subsequent K63-deubiquitination and K48-modification. These data 
put TAK1 in the center of the ubiquitin-editing process and a negative regulation 
feedback loop. However, I haven’t been able to identify the phosphorylation sites 
on Imd. Several rounds of mass-spectrometry analysis show inconsistent results 
that Imd is phosphorylated at multiple Serine and Threonine residues. Further 
experiments with more refined purification strategy, such as enrichment for 
phosphorylated Imd, is required to characterize the phosphorylation sites.
 TAK1 triggered K63-deubiquitination plays a crucial role in signaling 
modulation of Imd pathway. RNAi-based analysis suggest that both USP36 and 
Cyld function as deubiquitinating enzymes (DUB) and target Imd protein to down-
regulate signaling by removing the K63-polyubiquitin chains and thus disrupting 
its interaction with UBD-containing downstream factors. The exact model of how 
these two DUBs working together remains unclear. In addtion, knockdown of 
USP36 leads to severe viability issue. The cell survival rate measured by Trypan 
Blue staining shows a decrease from 90% (GFP RNAi) to 50% (USP36 RNAi), 
suggesting the involvement of USP36 in certain cell death pathway in addtion to 
immune signaling. To eliminate the effect of cell death on the Imd ubiquitin and 
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signaling assay, a feasible option is the ectopic expression of P35, a highly 
specific inhibitor of caspases that prevents apoptotic cell death but not inhibits 
Imd pathway in Drosophila cells (Hay et al., 1994, Kim et al., 2014).
 K63-deubiquitination and K48 conjugation have been show to be two 
closely related post-translational modifications. One of the best-studied DUBs is 
A20 (also known as TNFAIP3), which down-regulates NF-κB signaling through 
the cooperative activity of its two ubiquitin-editing domains. The N-terminal 
domain of A20, which is an OTU-type DUB domain, removes K63-linked ubiquitin 
chains from RIP1, an essential adaptor of the TNFR signaling. The C-terminal 
domain of A20, composed of seven zinc fingers, then functions as a ubiquitin 
ligase by conjugating RIP1 with K48-linked ubiquitin chains, thereby targeting 
RIP for proteasomal degradation (Wertz et al., 2004). The tumor suppressor Cyld 
in mammals is another DUB well known for it role in inhibiting NF-κB. Unlike A20, 
Cyld forms a complex with E3 ligase Itch through ‘WW-PPXY’ motif. This 
complex sequentially cleaves K63-linked ubiquitin and catalyzes K48 conjugation 
on TAK1, leading to termination of inflammatory TNF signaling (Ahmed et al., 
2011). Given the published evidence suggesting that Cyld is also a DUB 
targeting Imd signaling, it might exploit similar mechanism to promote the Imd 
ubiquitin-editing, in cooperation with the members of Drosophila homologue of 
Itch family, Nedd4, Smurf and/or Su(dx). The interaction between TAK1 and 
DUBs, as well as K48 ubiquitin E3 ligase, may underlie the mechanism 
regulating the ubiquitin-editing on Imd. The ubiquitin chains on Imd may function 
as scaffold to recruit TAK1 complex and DUBs, triggering the K63-
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deubiquitinaiton. Meanwhile, DUBs bring the E3 ligase of K48 chains to the 
proximity though certain binding motif, and initiate the K48 conjugation. To test 
this hypothesis, the key step is to establish the dynamics of the interactions 
described above. Characterization of binding motif will provide further evidence 
supporting this model. 
 When taken as a whole the data presented in this work resolve a number 
of questions in the field of insect innate immunity and allow remodeling of the Imd 
signal transduction pathway as a whole (Compare Figure 1.2 and Figure 2.15). 
Briefly, binding of PGN by PGRPs results in the DREDD dependent cleavage of 
Imd, which subsequently associates with the BIR repeats of E3 ligase DIAP2 and 
is then conjugated with K63-polyubiquitin chains in a two-step manner, catalyzed 
by Ubc5 and Ubc13/Uev1a respectively.  Ubiquitinated Imd then acts as a 
scaffold recruiting and activating TAK1 via TAB2 and signals through IKK 
complex, leading to activation of NF-κB protein Relish and induction of AMP 
genes. Most importantly, activated TAK1 initiates a feedback loop including Imd 
phosphorylation and ubiquitin-editing that replace the K63 chains with K48 
chains, leading to Imd degradation through proteasome. These findings provide 
further evidence supporting the two-step ubiquitination model, in addition to in 
vitro data, and reveal a novel mechanism that ubiquitin activated kinase 
modulate NF-κB signaling through promoting switch of ubiquitin from K63- to 
K48-linked chains. 
 Recent work highlights the complexity of ubiquitination and its important 
role in the regulation of signaling pathways in mammals and Drosophila. It will be 
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exciting to learn the similarity and difference of ubiquitination machinery in both 
systems. Lacking the adaptive immune response, Drosophila serves as an 
important model for further understanding of innate immunity and host/pathogen 
interactions. To that end this work will help to better understand the mechanisms 
signaling modulation by ubiquitin-editing in both mammalian and insect NF-κB 
pathway.
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